Mengfan Tang

1.4k citations
43 papers · 962 indexed · h-index 18
Topics
DNA Repair Mechanisms (23 papers)CRISPR and Genetic Engineering (15 papers)Ubiquitin and proteasome pathways (5 papers)
Partner nations
United StatesChina

In The Last Decade

Mengfan Tang

41 papers receiving 957 citations

Peers

Mengfan Tang
Comparison fields: 5 of 87
  • Molecular Biology 756
  • Oncology 286
  • Immunology 125
  • Cancer Research 86
  • Physiology 82
Replace Marco Mernberger with:
Marco Mernberger Germany
Irit Snir-Alkalay Israel
Ik Soo Kim South Korea
Hongmei Jiang China
Bert van de Kooij Netherlands
Kate E. Jarman Australia
Sylvia Fong United States
Delphine R. Boulbés United States
Lance R. Thomas United States
Y-X Zeng China
Mengfan Tang relative to Marco Mernberger Germany Marco Mernberger's profile →
Citations per field
00.5×3.5×
Marco Mernberger · 1×
Citations per year

Countries citing papers authored by Mengfan Tang

Since Specialization
Citations

This map shows the geographic impact of Mengfan Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengfan Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengfan Tang more than expected).

Fields of papers citing papers by Mengfan Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengfan Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengfan Tang. The network helps show where Mengfan Tang may publish in the future.

Co-authorship network of co-authors of Mengfan Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengfan Tang. A scholar is included among the top collaborators of Mengfan Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengfan Tang. Mengfan Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 9
5 9
6 25
7 13
8 26
9 28
10 7
11 15
12 5
13 62
14 94
15 31
16 1
17 21
18 31
19 107
20
DNA damage and repair in the initiation phase of carcinogenesis
5

About Mengfan Tang

Mengfan Tang is a scholar working on Molecular Biology, Oncology and Cell Biology, having authored 43 papers that have together received 962 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (23 papers), CRISPR and Genetic Engineering (15 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Molecular Biology (756 citations), Oncology (286 citations) and Aging (11 citations). Mengfan Tang has collaborated with scholars based in United States and China. Frequent co-authors include Junjie Chen, Chao Wang, Xu Feng, Huimin Zhang, Zhen Chen, Mrinal Srivastava, Dan Su, Litong Nie, Yun Xiong and Zhou Songyang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026